Encephalopathy and Delirium — Clinical Documentation Guide (2026)

🔍 Definition

Encephalopathy is a broad term for any diffuse brain dysfunction characterized by altered mental status, cognitive impairment, or changes in consciousness — caused by an underlying systemic, metabolic, toxic, or structural disorder. The term encompasses a spectrum from mild confusion to deep coma, and its etiology determines both the correct ICD-10-CM code and the clinical management approach.

Delirium (ICD-10-CM F05) is a specific neuropsychiatric syndrome characterized by an acute onset of fluctuating disturbance in attention, awareness, and cognition — not attributable to a pre-existing or evolving neurocognitive disorder, and not explained by a severely reduced level of arousal. Delirium is acute, reversible in most cases, and multifactorial, but a single etiology (e.g., medications, infection, metabolic derangement) often predominates.

For clinical documentation and coding purposes, the distinction between encephalopathy subtypes is critical: CMS ICD-10-CM FY2026 assigns different codes — and different MS-DRG weight impacts — depending on whether the condition is metabolic, toxic, anoxic, hepatic, uremic, hypertensive, or substance-induced. A non-specific "altered mental status" (R41.0) carries no CC/MCC, while documented metabolic encephalopathy (G93.41) triggers MCC status in most DRGs.

🗂️ Alternative Terminology

The following table maps commonly used clinical terms to their formal ICD-10-CM equivalents. Coders and CDI specialists should recognize all variants in physician documentation and query accordingly.

🩺 Signs & Symptoms

Recognizing the clinical presentation is essential for CDI specialists to identify query opportunities before physician attestation is secured. The following manifestations, when documented without an underlying confirmed diagnosis, represent prime query triggers.

🧭 Differential Diagnosis

A rigorous differential is the foundation of accurate documentation. The CDI specialist's role is to ensure the physician has documented to the appropriate level of specificity — not just "encephalopathy" but the etiological subtype, and not just "delirium" but whether it is due to a medical condition, substance use, or withdrawal.

📋 Clinical Indicators for Coders/CDI

The following clinical indicators, when present in the medical record, represent documentation gaps or query opportunities. CDI specialists should review these indicators during concurrent or retrospective review.

🦴 Anatomy & Pathophysiology

Understanding the underlying pathophysiology of encephalopathy and delirium enables CDI specialists to recognize when clinical findings are consistent with physician documentation — and when a query is warranted.

Normal Brain Function: The cerebral cortex and reticular activating system (RAS) maintain arousal, attention, and cognition through neurotransmitter balance (acetylcholine, dopamine, GABA, glutamate). The blood-brain barrier (BBB) protects neural tissue from systemic toxins.

Metabolic Encephalopathy Mechanism: Systemic metabolic derangements — elevated ammonia, uremic toxins, hyperglycemia/hypoglycemia, hypoxia, hypercapnia, electrolyte disturbances — penetrate or disrupt the BBB, impairing neuronal energy metabolism and neurotransmitter synthesis. Acetylcholine deficiency is a common final pathway, consistent with the inattention and cognitive impairment of delirium. Per UpToDate, the cholinergic hypothesis is supported by the propensity of anticholinergic medications to precipitate delirium.

Hepatic Encephalopathy: In liver failure, ammonia — normally metabolized by the urea cycle — accumulates in the systemic circulation. Ammonia crosses the BBB and is converted to glutamine in astrocytes, causing astrocyte swelling (osmotic effect) and neuronal excitotoxicity. Inflammatory cytokines from gut-derived infection synergize with ammonia to worsen encephalopathy. The American Association for the Study of Liver Diseases (AASLD) staging (West Haven criteria: Grade 0–IV) correlates with K72.xx coding acuity.

Toxic Encephalopathy: Exogenous neurotoxins — medications (opioids, benzodiazepines, anticholinergics, immunosuppressants), industrial chemicals, heavy metals — directly impair neuronal function. Polypharmacy is a major risk factor, particularly in elderly patients. The mechanism varies: receptor blockade, ion channel disruption, mitochondrial dysfunction, or direct cytotoxicity.

Anoxic Brain Damage (G93.1): Global cerebral ischemia (cardiac arrest, asphyxia) depletes neuronal ATP within 4–6 minutes, triggering glutamate-mediated excitotoxicity, calcium influx, and apoptotic cascades. Neurological injury severity correlates with duration of anoxia and is assessed by Cerebral Performance Category (CPC) scale and EEG pattern.

Wernicke's Encephalopathy (E51.2): Thiamine (vitamin B1) deficiency impairs the pyruvate dehydrogenase complex and transketolase enzymes, disrupting glucose metabolism in the thalamus, mammillary bodies, and brainstem. NINDS notes that without prompt thiamine replacement, the acute Wernicke's phase can progress to permanent Korsakoff amnestic syndrome.

💊 Medication Impact / Treatment

Medications play a dual role in encephalopathy and delirium: they are among the most common precipitants, and they are also the cornerstone of targeted treatment. Documentation of medication-related causality is critical for both accurate coding and CDI query development.

Medications That Precipitate or Worsen Encephalopathy/Delirium:

• Benzodiazepines: GABA-A agonists — impair attention and arousal; paradoxical agitation in elderly; withdrawal delirium on abrupt cessation. Associated with G92.x (toxic encephalopathy) when causative.
• Opioids: CNS depression, respiratory acidosis/hypercapnia, constipation (↑ ammonia). Naloxone-reversible. Opioid-induced encephalopathy → G92.x with T40.x poisoning code.
• Anticholinergics: (diphenhydramine, tricyclics, bladder agents, antiemetics) — block central acetylcholine, worsening the cholinergic deficit in delirium. High Anticholinergic Burden (ACB) score correlates with delirium risk.
• Antiepileptics: Valproate, levetiracetam, phenytoin — can cause drug-induced encephalopathy, especially at supratherapeutic levels.
• Steroids: Steroid-induced psychosis/delirium — document as "steroid-induced delirium" → F05 with appropriate T-code for adverse effect.
• Immunosuppressants/Chemotherapy: Tacrolimus, cyclosporine, methotrexate, ifosfamide → toxic encephalopathy (G92.x); distinguish from disease-related CNS involvement.
• Antibiotics: Cefepime (cefepime-induced neurotoxicity), fluoroquinolones, metronidazole — documented toxic encephalopathy → G92.x.

Therapeutic Agents (Treatment-Focused):

• Thiamine (Vitamin B1 / J3411): First-line and emergent for Wernicke's encephalopathy. High-dose IV thiamine (500 mg TID IV) per European Federation of Neurological Societies (EFNS) guidelines. HCPCS J3411 (thiamine HCl injection) — critical for Wernicke's documentation and coding.
• Lactulose: Reduces intestinal ammonia absorption — mainstay of hepatic encephalopathy management (K72.xx). Available Part D; oral/enema formulations. Titrate to 2–3 soft stools/day.
• Rifaximin: Antibiotic reducing gut ammonia-producing bacteria; used as adjunct/secondary prophylaxis in hepatic encephalopathy.
• Haloperidol: Low-dose IV/IM for acute agitation in delirium (evidence-based per SCCM PADIS Guidelines); Part D. Use with caution in alcohol withdrawal (not appropriate monotherapy for DTs).
• Quetiapine / Olanzapine: Second-generation antipsychotics for hyperactive delirium; Part D. Quetiapine commonly used in ICU delirium protocols.
• Dexmedetomidine (Precedex): Alpha-2 agonist; preferred sedation in mechanically ventilated patients to reduce delirium duration per SCCM PADIS Guidelines.
• Midazolam (J2250): Benzodiazepine indicated specifically for alcohol withdrawal delirium/DTs (F10.231); monitor for respiratory depression; not first-line for non-withdrawal delirium.
• IV Acetaminophen (J0131): Non-opioid analgesic alternative to reduce delirium-precipitating opioid burden in postoperative patients.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides